Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome

Recruiting N/A Interventional Study
Tourette Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
10 (estimated)
Sponsor
University Hospital, Bordeaux · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by the occurrence of involuntary movements (motor tics) and vocalizations (phonic tics). The onset of TS is usually in childhood, and the prevalence of TS is estimated between 0.3 and 0.9% before the age of 18, decreasing progressively after that age. Most patients also suffer from associated psychiatric comorbidities (A…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient at least 16 years old. * Disabling and drug-resistant Tourette's syndrome. * Receiving deep brain stimulation treatment with implantation of the PERCEPT™ Device as part of their medical management. * Normal brain MRI. * Subject affiliated or beneficiary of a social sec…
Contacts

Edouard COURTIN, Dr

05 57 82 12 42

edouard.courtin@chu-bordeaux.fr

CONTACT